On Jan. 11, 2021, TheNew York Times posted an article about the virtues of fecal immunochemical testing relative to colonoscopy. The story, “A Colonoscopy Alternative Comes Home” [https://www.nytimes.com/ 2021/ 01/ 11/ health/ colonoscopy-health-home-testing.html] depicted colonoscopy as a comparatively risky procedure with few advantages over less invasive methods of testing for colorectal cancer. It also offered the speculation that financial factors— namely, greater reimbursement for endoscopy—was behind the general preference of gastroenterologists for colonoscopy over stool tests.
Trending
- EndoQuest Robotics Announces Completion of Enrollment in the PARADIGM Trial (Business Wire)
- A single blood sample may improve the prediction of colorectal cancer recurrence or metastasis, kaist study finds (EurekAlert)
- At-Home Colorectal Cancer Tests Are Not a One-and-Done Deal (Cancer Health)
- How AI clears the way for colonoscopy screening (American Medical Association)
- Inside Diverticulitis: What Gastroenterologists Need to Know (Medscape)
- Abbott reports diagnostics growth since $21B Exact Sciences buy (Medtech Dive)
- Video Capsule Endoscopy Has Widening Role Beyond Diagnosis of Small-Bowel Bleeding (GI & Endoscopy News)
- How the AGA Incubator is shaping the future of digestive health (AGA)
